NCT01120847

Brief Summary

The current research program aims to study how sleep disordered breathing, age and genetics affect memory in older adult veterans with Posttraumatic Stress Disorder (PTSD). The study will help researchers and clinicians better understand the relationship among PTSD, sleep disordered breathing, genetics and memory function.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
324

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Sep 2004

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2004

Completed
5.7 years until next milestone

First Submitted

Initial submission to the registry

May 7, 2010

Completed
4 days until next milestone

First Posted

Study publicly available on registry

May 11, 2010

Completed
6.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 10, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 10, 2017

Completed
Last Updated

February 28, 2020

Status Verified

February 1, 2020

Enrollment Period

12.5 years

First QC Date

May 7, 2010

Last Update Submit

February 26, 2020

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change in Rey Auditory Verbal Learning Test-Measures auditory learning and memory

    This scale measures auditory learning and memory. The raw score range is 0-15 and scaled score range is 0-19.For raw and scaled scores, higher values represent a better outcome. Subscales are not combined to compute a composite score.

    annually

Secondary Outcomes (1)

  • APOE status

    sample taken at entry into study.

Study Arms (2)

Veterans with PTSD

No intervention; this is an observational study.

Control group w/out PTSD

No intervention; this is an observational study.

Eligibility Criteria

Age55 Years - 90 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

US war Veterans with PTSD and possible sleep problems

You may qualify if:

  • Age 55 years or older, male or female veterans of any racial or ethnic group.
  • PTSD subjects will be positive for lifetime PTSD, related to any past lifetime traumatic experience and have a diagnosis of current, chronic PTSD by the Clinician Administered PTSD Scale (CAPS) criteria with current CAPS score \> 40
  • Capable of giving informed consent for the study
  • Sufficient visual and auditory acuity for cognitive testing

You may not qualify if:

  • Current or lifetime history of any psychiatric disorder with psychotic features
  • Current or lifetime bipolar disorder or delusional disorder
  • Prominent suicidal or homicidal ideation
  • Current exposure to trauma or recent exposure to trauma in the past 3 months.
  • Currently or have within the past six months met DSM-IV criteria for drug or alcohol abuse or dependence (except nicotine).
  • Presence of alcohol intoxication (by breathalyzer) or alcohol withdrawal (by exam) during testing
  • Diagnosis of probable or possible dementia
  • Mini-Mental State Exam (MMSE) \< 23
  • History of seizure disorder.
  • Acute illness or unstable chronic illness (e.g., history of severe liver disease (cirrhosis, esophageal varices, ascites, portal hypertension, hepatic encephalopathy). Clinical or laboratory evidence of active hepatic disease will be recorded.
  • History of neurologic (e.g., multiple sclerosis, seizure disorder, stroke, history of transient ischemic attacks) or systemic illness affecting central nervous system (CNS) function (e.g. liver failure, kidney failure, congestive heart failure, systemic cancer)
  • Unstable or severe cardiovascular disease
  • Unstable gastrointestinal disorder
  • Uncontrolled hypertension
  • Head injury within one year
  • +4 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

VA Palo Alto Health Care System

Palo Alto, California, 94304, United States

Location

Biospecimen

Retention: SAMPLES WITH DNA

blood or saliva

MeSH Terms

Conditions

Stress Disorders, Post-Traumatic

Condition Hierarchy (Ancestors)

Stress Disorders, TraumaticTrauma and Stressor Related DisordersMental Disorders

Study Officials

  • Jerome A Yesavage

    Stanford University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

May 7, 2010

First Posted

May 11, 2010

Study Start

September 1, 2004

Primary Completion

March 10, 2017

Study Completion

March 10, 2017

Last Updated

February 28, 2020

Record last verified: 2020-02

Locations